PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 3, 2015Hemoglobin25 citations

Evaluating the Safety and Efficacy of Silymarin in β -Thalassemia Patients: A Review

View Full Paper
BEBehjat Al-Sadat Moayedi EsfahaniNRNahid ReisiMMMilad Mirmoghtadaei

Key Points

Key points are not available for this paper at this time.

Abstract

Behjat Al-Sadat Moayedi Esfahania, Nahid Reisib* however, DFX is very expensive and the cost is a significant new burden for patients. Recently, researchers have proposed an iron chelating effect for silymarin that is a flavonoid extract from the milk thistle plant. This extract has different properties and has long been used for its antioxidant and hepatoprotective effects. In this review we assess different aspects of silymarin’s potential effects and compare them to the profile of thalassemic patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Esfahani et al. (2015) studied this question.

synapsesocial.com/papers/6a901e6e11fe3daa372b0d4fhttps://doi.org/10.3109/03630269.2014.1003224
Ask AI
Helpful
Bookmark
Share
View Full Paper